Promoting awareness of terminology related to unmet medical needs in context of rheumatic diseases in Japan: a systematic review for evaluating unmet medical needs
Tóm tắt
Từ khóa
Tài liệu tham khảo
Vreman RA, Heikkinen I, Schuurman A, Sapede C, Garcia JL, Hedberg N, Athanasiou D, Grueger J, Leufkens HGM, Goettsch WG (2019) Unmet medical need: an introduction to definitions and stakeholder perceptions. Value Health 22(11):1275–1282. https://doi.org/10.1016/j.jval.2019.07.007
Falk IS (1944) Content and administration of a medical care program: unmet health needs. Am J Public Health Nations Health 34(12):1223–1230. https://doi.org/10.2105/ajph.34.12.1223
Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E, Borge CR, Engebretsen E, Eisemann M, Halvorsrud L, Hanssen TA, Haugstvedt A, Haugland T, Johansen VA, Larsen MH, Løvereide L, Løyland B, Kvarme LG, Moons P, Norekvål TM, Ribu L, Rohde GE, Urstad KH, Helseth S, LIVSFORSK network (2019) A systematic review of quality of life research in medicine and health sciences. Qual Life Res 28(10):2641–2650. https://doi.org/10.1007/s11136-019-02214-9
Bansal D, Bhagat A, Schifano F, Gudala K (2015) Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008–2012). J Epidemiol Glob Health 5(4):385–395. https://doi.org/10.1016/j.jegh.2015.04.006
Wahl ER, Yazdany J (2016) Challenges and opportunities in using patient-reported outcomes in quality measurement in rheumatology. Rheum Dis Clin N Am 42(2):363–375. https://doi.org/10.1016/j.rdc.2016.01.008
Knight E, Schifferdecker KE, Eakin GS, Reeve BB (2023) Selecting patient-reported outcome measures of health-related quality of life in adult rheumatology: quality and breadth of coverage. Rheumatol Int 43(4):627–638. https://doi.org/10.1007/s00296-022-05200-6
Hays RD, Hahn H, Marshall G (2002) Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities. Arch Phys Med Rehabil 83(suppl 2):S4–S9. https://doi.org/10.1053/apmr.2002.36837
Leong KP, Kong KO, Thong BY, Koh ET, Lian TY, Teh CL, Cheng YK, Chng HH, Badsha H, Law WG, Lau TC, Chew LC, Ho HJ, Pong LY, Hoi LS, Sangeetha N, Chan SP, Howe HS (2005) Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatol (Oxf Engl) 44(10):1267–1276. https://doi.org/10.1093/rheumatology/keh605
McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, Peers K, Isenberg D, Ferenkeh-Koroma A, Griffiths B, Akil M, Maddison P, Teh LS (2007) Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum 57(6):972–979. https://doi.org/10.1002/art.22881
Moses N, Wiggers J, Nicholas C, Cockburn J (2007) Development and psychometric analysis of the systemic lupus erythematosus needs questionnaire (SLENQ). Qual Life Res 16(3):461–466. https://doi.org/10.1007/s11136-006-9137-5
Doward LC, McKenna SP, Whalley D, Tennant A, Griffiths B, Emery P, Veale DJ (2009) The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 68(2):196–200. https://doi.org/10.1136/ard.2007.086009
Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, Rodby RA, Fogg L, Sequeira W, Utset TO, Cash TF, Moldovan I, Katsaros E, Nicassio P, Ishimori ML, Kosinsky M, Merrill JT, Weisman MH, Wallace DJ (2012) Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum 42(1):56–65. https://doi.org/10.1016/j.semarthrit.2011.12.005
Moons P, Budts W, De Geest S (2006) Critique on the conceptualisation of quality of life: a review and evaluation of different conceptual approaches. Int J Nurs Stud 43(7):891–901. https://doi.org/10.1016/j.ijnurstu.2006.03.015
Moses N, Wiggers J, Nicholas C, Cockburn J (2005) Prevalence and correlates of perceived unmet needs of people with systemic lupus erythematosus. Patient Educ Couns 57(1):30–38. https://doi.org/10.1016/j.pec.2004.03.015
Moses N, Wiggers J, Nicholas C (2008) Persistence of unmet need for care among people with systemic lupus erythematosus: a longitudinal study. Qual Life Res 17(6):867–876. https://doi.org/10.1007/s11136-008-9361-2
Danoff-Burg S, Friedberg F (2009) Unmet needs of patients with systemic lupus erythematosus. Behav Med 35(1):5–13. https://doi.org/10.3200/BMED.35.1.5-13
Alibaz-Oner F, Mumcu G, Kubilay Z, Ozen G, Celik G, Karadeniz A, Can M, Oner SY, Inanc N, Atagunduz P, Ergun T, Direskeneli H (2014) Unmet need in Behcet’s disease: Most patients in routine follow-up continue to have oral ulcers. Clin Rheumatol 33(12):1773–1776. https://doi.org/10.1007/s10067-014-2585-3
Barry RJ, Markandey B, Malhotra R, Knott H, Joji N, Mubin M, Denniston AK, Murray PI (2014) Evidence-based practice in Behçet’s disease: identifying areas of unmet need for 2014. Orphanet J Rare Dis 9:16. https://doi.org/10.1186/1750-1172-9-16
Nikpour M, Bridge JA, Richter S (2014) A systematic review of prevalence, disease characteristics and management of systemic lupus erythematosus in Australia: identifying areas of unmet need. Intern Med J 44(12a):1170–1179. https://doi.org/10.1111/imj.12568
Kuhn A, Landmann A, Bonsmann G (2016) The skin in autoimmune diseases-unmet needs. Autoimmun Rev 15(10):948–954. https://doi.org/10.1016/j.autrev.2016.07.013
Bibby H, White V, Thompson K, Anazodo A (2017) What are the unmet needs and care experiences of adolescents and young adults with cancer? A systematic review. J Adolesc Young Adult Oncol 6(1):6–30. https://doi.org/10.1089/jayao.2016.0012
Winthrop KL, Strand V, van der Heijde D, Mease P, Crow M, Weinblatt M, Bathon J, Burmester GR, Dougados M, Kay J, Mariette X, Van Vollenhoven R, Sieper J, Melchers F, Breedfeld FC, Kalden J, Smolen JS, Furst DE (2018) The unmet need in rheumatology: reports from the targeted therapies meeting 2017. Clin Immunol 186:87–93. https://doi.org/10.1016/j.clim.2017.08.009
Winthrop KL, Weinblatt ME, Crow MK, Burmester GR, Mease PJ, So AK, Bykerk V, Van Vollenhoven RF, Dougados M, Kay J, Mariette X, Sieper J, Melchers F, Cronstein BN, Shevach E, Breedfeld FC, Kalden J, Smolen JS, Furst DE (2019) Unmet need in rheumatology: reports from the targeted therapies meeting 2018. Ann Rheum Dis 78(7):872–878. https://doi.org/10.1136/annrheumdis-2018-214280
Winthrop KL, Weinblatt ME, Bathon J, Burmester GR, Mease PJ, Crofford L, Bykerk V, Dougados M, Rosenbaum JT, Mariette X, Sieper J, Melchers F, Cronstein BN, Breedveld FC, Kalden J, Smolen JS, Furst D (2020) Unmet need in rheumatology: reports from the targeted therapies meeting 2019. Ann Rheum Dis 79(1):88–93. https://doi.org/10.1136/annrheumdis-2019-216151
Ishiguro M, Hashizume H, Ikeda T, Yamamoto Y, Furukawa F (2014) Evaluation of the quality of life of lupus erythematosus patients with cutaneous lesions in Japan. Lupus 23(1):93–101. https://doi.org/10.1177/0961203313509293
Furukawa M, Kiyohara C, Horiuchi T, Tsukamoto H, Mitoma H, Kimoto Y, Uchino A, Nakagawa M, Oryoji K, Shimoda T, Akashi K (2016) Quality of life in Japanese female patients with systemic lupus erythematosus: evaluation using the Short Form 36 Health Survey. Mod Rheumatol 26(2):240–247. https://doi.org/10.3109/14397595.2015.1060668
Baba S, Katsumata Y, Okamoto Y, Kawaguchi Y, Hanaoka M, Kawasumi H, Yamanaka H (2018) Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study. Lupus 27(3):407–416. https://doi.org/10.1177/0961203317725586
Doi H, Ohmura K, Tabuchi Y, Hashimoto M, Takase Y, Inaba R, Kozuki T, Iwasaki T, Taniguchi M, Kitagori K, Akizuki S, Murakami K, Nakashima R, Yoshifuji H, Yamamoto W, Tanaka M, Akio M (2021) Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life. Lupus 30(7):1108–1115. https://doi.org/10.1177/09612033211005026
Miyawaki Y, Shimizu S, Ogawa Y, Sada KE, Katayama Y, Asano Y, Hayashi K, Yamamura Y, Hiramatsu-Asano S, Ohashi K, Morishita M, Watanabe H, Takano-Narazaki M, Matsumoto Y, Yajima N, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Ichinose K, Sato S, Fujiwara M, Yamazaki H, Yamamoto Y, Wada J, Fukuhara S (2021) Association of glucocorticoid doses and emotional health in lupus low disease activity state (LLDAS): a cross-sectional study. Arthritis Res Ther 23(1):79. https://doi.org/10.1186/s13075-021-02466-2
Takase Y, Iwasaki T, Doi H, Tsuji H, Hashimoto M, Ueno K, Inaba R, Kozuki T, Taniguchi M, Tabuchi Y, Watanabe R, Kitagori K, Akizuki S, Murakami K, Nakashima R, Yoshifuji H, Itaya T, Yamamoto W, Uozumi R, Tanaka M, Ohmura K, Morinobu A (2021) Correlation between irreversible organ damage and the quality of life of patients with systemic lupus erythematosus: the Kyoto lupus Cohort survey. Lupus 30(10):1577–1585. https://doi.org/10.1177/09612033211025614
Kawasumi H, Gono T, Kawaguchi Y, Kuwana M, Kaneko H, Katsumata Y, Kataoka S, Hanaoka M, Yamanaka H (2016) Clinical manifestations and myositis-specific autoantibodies associated with physical dysfunction after treatment in polymyositis and dermatomyositis: an observational study of physical dysfunction with myositis in Japan. BioMed Res Int 2016:9163201. https://doi.org/10.1155/2016/9163201
Azuma N, Katada Y, Yoshikawa T, Yokoyama Y, Nishioka A, Sekiguchi M, Kitano M, Kitano S, Sano H, Matsui K (2021) Evaluation of changes in oral health-related quality of life over time in patients with Sjögren’s syndrome. Mod Rheumatol 31(3):669–677. https://doi.org/10.1080/14397595.2020.1795391
Miyauchi K, Fujimoto K, Abe T, Takei M, Ogawa K (2021) Cross-sectional assessment of sleep and fatigue in middle-aged Japanese women with primary Sjogren syndrome or rheumatoid arthritis using self-reports and wrist actigraphy. Med (Baltim) 100(37):e27233. https://doi.org/10.1097/MD.0000000000027233
Matsuura E, Ohta A, Suematsu R, Inoue H, Koarada S, Tada Y, Sherriff-Tadano R, Kuroki T, Ikeda D, Nagasawa K (2011) Functional disturbance of the stress-adaptation system in patients with scleroderma. Mod Rheumatol 21(4):397–405. https://doi.org/10.1007/s10165-010-0412-5
Yoshimasu T, Ikeda T, Uede K, Kanazawa N, Furukawa F (2012) Effects of sarpogrelate hydrochloride on skin ulcers and quality of life in patients with systemic sclerosis. J Dermatol 39(6):536–540. https://doi.org/10.1111/j.1346-8138.2011.01432.x
Mugii N, Someya F, Noto S, Hamaguchi Y, Matsushita T, Takehara K (2020) Availability of EuroQol-5-dimensions-5-LEVEL (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients. Mod Rheumatol 30(4):681–686. https://doi.org/10.1080/14397595.2019.1640409
Sakai T, Watanabe H, Kuroyanagi K, Akiyama G, Okano K, Kohno H, Tsuneoka H (2013) Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis. Br J Ophthalmol 97(3):338–342. https://doi.org/10.1136/bjophthalmol-2012-302515
Nagano A, Takeuchi M, Horita N, Teshigawara T, Kawagoe T, Mizuki Y, Meguro A, Nakano H, Kirino Y, Takase-Minegishi K, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Kaneko T, Mizuki N (2022) Behçet’s disease and activities of daily living. Rheumatol (Oxf Engl) 61(3):1133–1140. https://doi.org/10.1093/rheumatology/keab499
Tsutsui H, Kikuchi H, Oguchi H, Kono H, Ohkubo T (2022) Validity and reliability of a checklist for patients with Behçet’s disease based on the International Classification of Functioning. Disabil Health Rheumatol Int 42(1):159–165. https://doi.org/10.1007/s00296-021-05001-3
Inoue M, Shiozawa K, Yoshihara R, Yamane T, Shima Y, Hirano T, Makimoto K (2017) Predictors of poor sleep quality in patients with systemic lupus erythematosus. Clin Rheumatol 36(5):1053–1062. https://doi.org/10.1007/s10067-017-3545-5
Takahashi H, Washio M, Kiyohara C, Tada Y, Asami T, Ide S, Atsumi T, Kobashi G, Yamamoto M, Horiuchi T (2014) Psychological stress in a Japanese population with systemic lupus erythematosus: finding from KYSS study. Mod Rheumatol 24(3):448–452. https://doi.org/10.3109/14397595.2013.843745
Washio M, Fujii T, Kuwana M, Kawaguchi Y, Mimori A, Horiuchi T, Tada Y, Takahashi H, Mimori T, Japan MCTD study group (2014) Lifestyle and other related factors for the development of mixed connective tissue disease among Japanese females in comparison with systemic lupus erythematosus. Mod Rheumatol 24(5):788–792. https://doi.org/10.3109/14397595.2013.863442
Tanaka Y, Mizukami A, Kobayashi A, Ito C, Matsuki T (2018) Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: a retrospective, observational study. Int J Rheum Dis 21(8):1609–1618. https://doi.org/10.1111/1756-185X.13363
Miyazaki C, Sruamsiri R, Mahlich J, Jung W (2020) Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study. J Med Econ 23(7):786–799. https://doi.org/10.1080/13696998.2020.1740236
Matsui T, Matsumoto T, Hirano F, Tokunaga F, Okamoto K, Tohma S, Morio T, Kohsaka H, Mori M (2018) Survey of the awareness of adult rheumatologists regarding transitional care for patients with juvenile idiopathic arthritis in Japan. Mod Rheumatol 28(6):981–985. https://doi.org/10.1080/14397595.2018.1430546
Matsumoto T, Mori M (2021) Questionnaire survey on transitional care for patients with juvenile idiopathic arthritis (JIA) and families. Mod Rheumatol 31(3):691–696. https://doi.org/10.1080/14397595.2020.1813369
Matsuda S, Ohtomo T, Tomizawa S, Miyano Y, Mogi M, Kuriki H, Nakayama T, Watanabe S (2021) Incorporating unstructured patient narratives and health insurance claims data in pharmacovigilance: natural language processing analysis of patient-generated texts about systemic lupus erythematosus. JMIR Public Health Surveill 7(6):e29238. https://doi.org/10.2196/29238
Kurita N, Oguro N, Miyawaki Y, Hidekawa C, Sakurai N, Ichikawa T, Ishikawa Y, Hayashi K, Shidahara K, Kishida D, Yoshimi R, Sada KE, Shimojima Y, Yajima N (2023) Trust in the attending rheumatologist, health-related hope, and medication adherence among Japanese systemic lupus erythematosus patients. Rheumatol (Oxf Engl) 62(6):2147–2153. https://doi.org/10.1093/rheumatology/keac565
Miyake H, Sada RM, Akebo H, Tsugihashi Y, Hatta K (2022) Polypharmacy prevalence and associated factors in patients with systemic lupus erythematosus: a single-centre, cross-sectional study. Mod Rheumatol. https://doi.org/10.1093/mr/roac155
Phillips R, Pell B, Grant A, Bowen D, Sanders J, Taylor A, Edwards A, Choy E, Williams D (2018) Identifying the unmet information and support needs of women with autoimmune rheumatic diseases during pregnancy planning, pregnancy and early parenting: mixed-methods study. BMC Rheumatol 2:21. https://doi.org/10.1186/s41927-018-0029-4
Murray K, Moore L, O’Brien C, Clohessy A, Brophy C, FitzGerald O, Molloy ES, Mongey AB, Higgins S, Higgins MF, Minnock P, Lalor J, McAuliffe FM, Veale DJ (2020) A multidisciplinary approach to reproductive healthcare in women with rheumatic disease. Ir J Med Sci 189(1):237–243. https://doi.org/10.1007/s11845-019-02040-5
Søvik ML, Eide REM, Rene B, Strand MM, Devik I, Liland DE, Kjeken I, Taule T (2021) Rheumatic disease and fatigue: participants’ experiences of an activity-pacing group. Scand J Occup Ther. https://doi.org/10.1080/11038128.2021.1998609
Gheita TA, Eesa NN (2019) Rheumatology in Egypt: back to the future. Rheumatol Int 39(1):1–12. https://doi.org/10.1007/s00296-018-4192-0
Maślińska M, Dobrzyński T, Kwiatkowska B (2019) Rheumatology in Poland. Rheumatol Int 39(5):757–767. https://doi.org/10.1007/s00296-019-04287-8
Doskaliuk B, Zimba O, Yatsyshyn R, Kovalenko V (2020) Rheumatology in Ukraine. Rheumatol Int 40(2):175–182. https://doi.org/10.1007/s00296-019-04504-4